Maze Therapeutics, Inc.(MAZE)
$31.20-1.67 (-5.08%)
MAZE
Maze Therapeutics, Inc. earnings date
$31.20
At close:-1.67 (-5.08%)
Want to see MAZE full AI Analyst Report?
Maze Therapeutics, Inc. (MAZE) Q2 2026 Earnings Report
128 Followers
MAZE Q2 2026 EPS Results
- Actual EPS
- -$0.76
- Consensus EPS
- -$0.72
- Beat/Miss
- Missed by -$0.04
- One Year Ago EPS
- -$0.77
MAZE Q2 2026 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $2.86M
- Beat/Miss
- Missed by -$2.86M
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/11/2026
- Time
- After Close
- Conference Call
- Tuesday, August 11, 2026
MAZE Upcoming Earnings
Maze Therapeutics, Inc.'s next earnings date is estimated for April 5, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
MAZE Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Apr 05, 2027 | 2026 (Q4) | -0.83- | -0.45 | ― | ― |
| Nov 09, 2026 | 2026 (Q3) | -0.76-0.79 | -0.66 | -19.70% (-0.13) | |
| Aug 11, 2026 | 2026 (Q2) | -0.72-0.76 | -0.77 | 1.30% (+0.01) | |
| May 12, 2026 | 2026 (Q1) | -0.58-0.45 | -1.15 | 60.87% (+0.70) | |
| Apr 06, 2026 | 2025 (Q4) | -0.71-0.65 | -18.32 | 96.45% (+17.67) | |
| Nov 06, 2025 | 2025 (Q3) | -0.71-0.66 | -0.06 | -1100.00% (-0.60) | |
| Aug 12, 2025 | 2025 (Q2) | -0.84-0.77 | ― | ― | |
| May 14, 2025 | 2025 (Q1) | ―- | -0.74 | ― | |
| Mar 31, 2025 | 2024 (Q4) | -0.72-1.15 | -0.74 | -54.99% (-0.41) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

